Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review
Objectives Reported rates of major complications and mortality of radiofrequency ablation
(RFA), microwave ablation (MWA) and percutaneous ethanol injection (PEI) for the treatment …
(RFA), microwave ablation (MWA) and percutaneous ethanol injection (PEI) for the treatment …
[HTML][HTML] Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion
AS Mathew, EG Atenafu, D Owen, C Maurino… - European Journal of …, 2020 - Elsevier
Abstract Background Stereotactic Body Radiation Therapy (SBRT) is a non-invasive ablative
treatment for hepatocellular carcinoma (HCC). This report aimed to address the limited …
treatment for hepatocellular carcinoma (HCC). This report aimed to address the limited …
Ablation of liver cancer cells in vitro by a plasma needle
X Zhang, M Li, R Zhou, K Feng, S Yang - Applied Physics Letters, 2008 - pubs.aip.org
A plasma needle using a dielectric barrier discharge reactor at atmospheric pressure with a
funnel-shaped nozzle was developed. The preliminary characteristics of the plume and …
funnel-shaped nozzle was developed. The preliminary characteristics of the plume and …
[HTML][HTML] Complications after percutaneous ablation of liver tumors: a systematic review
E Lahat, R Eshkenazy, A Zendel, BB Zakai… - … surgery and nutrition, 2014 - ncbi.nlm.nih.gov
Background Although ablation therapy has been accepted as a promising and safe
technique for treatment of unrespectable hepatic tumors, investigation of its complications …
technique for treatment of unrespectable hepatic tumors, investigation of its complications …
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study
Background Whether percutaneous radiofrequency ablation (PRFA) is as effective as repeat
hepatectomy for recurrent small hepatocellular carcinoma (HCC) in the long-term remains …
hepatectomy for recurrent small hepatocellular carcinoma (HCC) in the long-term remains …
Percutaneous ablation of hepatocellular carcinoma: current status
Hepatocellular carcinoma (HCC) is an increasingly common disease with dismal long-term
survival. Percutaneous ablation has gained popularity as a minimally invasive, potentially …
survival. Percutaneous ablation has gained popularity as a minimally invasive, potentially …
Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study
Purpose To compare the long-term outcomes of repeated hepatic resection and
radiofrequency (RF) ablation for recurrent hepatocellular carcinoma (HCC) by using …
radiofrequency (RF) ablation for recurrent hepatocellular carcinoma (HCC) by using …
Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver
T Li, J Fan, LX Qin, J Zhou, HC Sun, SJ Qiu… - Annals of surgical …, 2011 - Springer
Background Primary clear cell carcinoma of the liver (PCCCL) is an uncommon variant of
hepatocellular carcinoma (HCC). The prognostic factors influencing its recurrence and …
hepatocellular carcinoma (HCC). The prognostic factors influencing its recurrence and …
Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection
RL Meniconi, S Komatsu, F Perdigao, PY Boëlle… - Surgery, 2015 - Elsevier
Background Hepatocellular carcinoma (HCC) often recurs after curative resection, and thus
the optimal treatment strategy to treat recurrences remains uncertain. We analyzed the …
the optimal treatment strategy to treat recurrences remains uncertain. We analyzed the …
Ablation of hepatocellular carcinoma
Radiofrequency ablation (RFA) has gained a wide acceptance as a first-line therapeutic
option for small hepatocellular carcinoma (HCC). For very early-stage HCC, despite a higher …
option for small hepatocellular carcinoma (HCC). For very early-stage HCC, despite a higher …